Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Operating room turnover time autocorrelation while using mobile applications.

Uddin M, Allen R, Huynh N, Vidal JM, Taaffe KM, Fredendall LD, Greenstein JS.

Mhealth. 2018 Sep 12;4:38. doi: 10.21037/mhealth.2018.09.07. eCollection 2018. No abstract available.

2.

Assessing operating room turnover time via the use of mobile application.

Uddin M, Allen R, Huynh N, Vidal JM, Taaffe KM, Fredendall LD, Greenstein JS.

Mhealth. 2018 May 17;4:12. doi: 10.21037/mhealth.2018.05.03. eCollection 2018.

3.

Phylogenetic studies in Genabea, Myrmecocystis, and related genera.

Alvarado P, Healy R, Moreno G, Cabero J, Scholler M, Schneider A, Vizzini A, Kaounas V, Vidal JM, Hensel G, Rubio E, Mujic A, Smith ME.

Mycologia. 2018 Mar-Apr;110(2):401-418. doi: 10.1080/00275514.2018.1451140. Epub 2018 May 24.

PMID:
29792783
4.

Modified Hybrid Procedure in Hypoplastic Left Heart Syndrome: Initial Experience of a Center in Northeastern Brazil.

Faria RM, Pacheco JT, Oliveira IR, Vidal JM, Rodrigues AB Junior, Costa ALL, Nina VJDS, Cascudo MM.

Braz J Cardiovasc Surg. 2017 May-Jun;32(3):210-214. doi: 10.21470/1678-9741-2017-0058.

5.

[Psychosocial stress at work and alcohol consumption patterns in offshore oil workers].

Vidal JM, Abreu AM, Portela LF.

Cad Saude Publica. 2017 Jul 13;33(6):e00116616. doi: 10.1590/0102-311Xe00116616. Portuguese.

6.

Assessment of the Nurse Medication Administration Workflow Process

Huynh N, Snyder R, Vidal JM, Sharif O, Cai B, Parsons B, Bennett K.

J Healthc Eng. 2016;2016. doi: 10.1155/2016/6823185.

7.

Assessment of the Nurse Medication Administration Workflow Process.

Huynh N, Snyder R, Vidal JM, Sharif O, Cai B, Parsons B, Bennett K.

J Healthc Eng. 2016;2016:6823185. doi: 10.1155/2016/6823185. Epub 2016 Jul 17.

8.
9.

Critical review on the Environmental Risk Assessment of medicinal products for human use in the centralised procedure.

Caneva L, Bonelli M, Papaluca-Amati M, Vidal JM.

Regul Toxicol Pharmacol. 2014 Apr;68(3):312-6. doi: 10.1016/j.yrtph.2014.01.002. Epub 2014 Jan 18. Review.

PMID:
24447908
10.

Inhibition of Flavobacterium psychrophilum biofilm formation using a biofilm of the antagonist Pseudomonas fluorescens FF48.

De la Fuente M, Vidal JM, Miranda CD, González G, Urrutia H.

Springerplus. 2013 Apr 22;2(1):176. doi: 10.1186/2193-1801-2-176. Print 2013 Dec.

11.

Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines.

Ehmann F, Sakai-Kato K, Duncan R, Hernán Pérez de la Ossa D, Pita R, Vidal JM, Kohli A, Tothfalusi L, Sanh A, Tinton S, Robert JL, Silva Lima B, Amati MP.

Nanomedicine (Lond). 2013 May;8(5):849-56. doi: 10.2217/nnm.13.68. Review.

PMID:
23656268
12.

Indications of microsurgery in soft tissue sarcomas.

Viñals JM, Rodrigues TA, Sildenikova DP, Payro JM, Porté JA, Suñe CH, Ojeda AL, Vidal JM, Dewever M, Lopez CC, Segu JO, Chavarria FA.

J Reconstr Microsurg. 2012 Nov;28(9):619-25. doi: 10.1055/s-0032-1326740. Epub 2012 Sep 21.

PMID:
23023807
13.

Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).

Kinsner-Ovaskainen A, Maxwell G, Kreysa J, Barroso J, Adriaens E, Alépée N, Berg N, Bremer S, Coecke S, Comenges JZ, Corvi R, Casati S, Dal Negro G, Marrec-Fairley M, Griesinger C, Halder M, Heisler E, Hirmann D, Kleensang A, Kopp-Schneider A, Lapenna S, Munn S, Prieto P, Schechtman L, Schultz T, Vidal JM, Worth A, Zuang V.

Altern Lab Anim. 2012 Jul;40(3):175-81.

PMID:
22943518
14.

Chlorate reduction capacity and characterisation of chlorate reducing bacteria communities in sediments of the rio Cruces wetland in southern Chile.

Schwarz AO, Urrutia H, Vidal JM, Pérez N.

Water Res. 2012 Jun 15;46(10):3283-92. doi: 10.1016/j.watres.2012.03.046. Epub 2012 Mar 31.

PMID:
22516175
15.

A generic operational strategy to qualify translational safety biomarkers.

Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B.

Drug Discov Today. 2011 Jul;16(13-14):600-8. doi: 10.1016/j.drudis.2011.04.011. Epub 2011 May 6. Review.

PMID:
21570476
16.

[Risk groups in differentiated thyroid carcinomas].

Herránz González-Botas J, Barro CV, Vidal JM.

Acta Otorrinolaringol Esp. 2011 Jan-Feb;62(1):14-9. doi: 10.1016/j.otorri.2010.09.007. Epub 2010 Nov 26. Spanish.

17.

Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study).

García-Castelo A, García-Seara J, Otero-Raviña F, Lado M, Vizcaya A, Vidal JM, Lafuente R, Bouza D, Lear PV, González-Juanatey JR; Barbanza Group Investigators.

Int J Cardiol. 2011 Nov 17;153(1):68-73. doi: 10.1016/j.ijcard.2010.08.042. Epub 2010 Sep 16.

PMID:
20837367
18.

Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors.

Silva-Lima B, Due Theilade-Thomsen M, Carleer J, Vidal JM, Tomasi P, Saint-Raymond A.

Birth Defects Res B Dev Reprod Toxicol. 2010 Dec;89(6):467-73. doi: 10.1002/bdrb.20257.

PMID:
20632393
19.

In vitro cytokine release assays for predicting cytokine release syndrome: the current state-of-the-science. Report of a European Medicines Agency Workshop.

Vidal JM, Kawabata TT, Thorpe R, Silva-Lima B, Cederbrant K, Poole S, Mueller-Berghaus J, Pallardy M, Van der Laan JW.

Cytokine. 2010 Aug;51(2):213-5. doi: 10.1016/j.cyto.2010.04.008. Epub 2010 May 14. No abstract available.

PMID:
20471854
20.

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium.

Dieterle F, Sistare F, Goodsaid F, Papaluca M, Ozer JS, Webb CP, Baer W, Senagore A, Schipper MJ, Vonderscher J, Sultana S, Gerhold DL, Phillips JA, Maurer G, Carl K, Laurie D, Harpur E, Sonee M, Ennulat D, Holder D, Andrews-Cleavenger D, Gu YZ, Thompson KL, Goering PL, Vidal JM, Abadie E, Maciulaitis R, Jacobson-Kram D, Defelice AF, Hausner EA, Blank M, Thompson A, Harlow P, Throckmorton D, Xiao S, Xu N, Taylor W, Vamvakas S, Flamion B, Lima BS, Kasper P, Pasanen M, Prasad K, Troth S, Bounous D, Robinson-Gravatt D, Betton G, Davis MA, Akunda J, McDuffie JE, Suter L, Obert L, Guffroy M, Pinches M, Jayadev S, Blomme EA, Beushausen SA, Barlow VG, Collins N, Waring J, Honor D, Snook S, Lee J, Rossi P, Walker E, Mattes W.

Nat Biotechnol. 2010 May;28(5):455-62. doi: 10.1038/nbt.1625. Epub 2010 May 10.

PMID:
20458315
21.

Towards consensus practices to qualify safety biomarkers for use in early drug development.

Sistare FD, Dieterle F, Troth S, Holder DJ, Gerhold D, Andrews-Cleavenger D, Baer W, Betton G, Bounous D, Carl K, Collins N, Goering P, Goodsaid F, Gu YZ, Guilpin V, Harpur E, Hassan A, Jacobson-Kram D, Kasper P, Laurie D, Lima BS, Maciulaitis R, Mattes W, Maurer G, Obert LA, Ozer J, Papaluca-Amati M, Phillips JA, Pinches M, Schipper MJ, Thompson KL, Vamvakas S, Vidal JM, Vonderscher J, Walker E, Webb C, Yu Y.

Nat Biotechnol. 2010 May;28(5):446-54. doi: 10.1038/nbt.1634. Epub 2010 May 10.

PMID:
20458314
22.

[Primary non-Hodgkin lymphoma of the parotid gland: Revision of 8 cases].

Alvarez-Buylla Blanco M, Martínez Moran A, Vázquez Barro JC, Vidal JM.

Acta Otorrinolaringol Esp. 2010 Sep-Oct;61(5):371-4. doi: 10.1016/j.otorri.2010.02.002. Epub 2010 Mar 25. Spanish.

23.

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Wang J, Van Damme P, Cruchaga C, Gitcho MA, Vidal JM, Seijo-Martínez M, Wang L, Wu JY, Robberecht W, Goate A.

J Neurochem. 2010 Mar;112(5):1305-15. doi: 10.1111/j.1471-4159.2009.06546.x. Epub 2009 Dec 17.

24.

Intracellular protein degradation in mammalian cells: recent developments.

Knecht E, Aguado C, Cárcel J, Esteban I, Esteve JM, Ghislat G, Moruno JF, Vidal JM, Sáez R.

Cell Mol Life Sci. 2009 Aug;66(15):2427-43. doi: 10.1007/s00018-009-0030-6. Epub 2009 Apr 28. Review.

PMID:
19399586
25.

Development of the ICH guidelines for immunotoxicology evaluation of pharmaceuticals using a survey of industry practices.

Weaver JL, Tsutsui N, Hisada S, Vidal JM, Spanhaak S, Sawada J, Hastings KL, van der Laan JW, van Loveren H, Kawabata TT, Sims J, Durham SK, Fueki O, Matula TI, Kusunoki H, Ulrich P, Nakamura K.

J Immunotoxicol. 2005 Jul 1;2(3):171-80. doi: 10.1080/15476910500241339.

PMID:
18958670
26.

Effect of the haematocrit layer geometry on Plasmodium falciparum static thin-layer in vitro cultures.

Ferrer J, Rosal MD, Vidal JM, Prats C, Valls J, Herreros EA, López D, Gargallo D.

Malar J. 2008 Oct 8;7:203. doi: 10.1186/1475-2875-7-203.

27.

Optimisation of the post-validation process: the report and recommendations of ECVAM Workshop 67.

Bottini AA, Alepee N, Phillips B, Gribaldo L, De Silva O, Hartung T, Hendriksen C, Kuil J, Pazos P, Rhein C, Schiffelers MJ, Stokes W, Theobald A, Vidal JM, Van de Sandt H, Breier S, Sintes JR, Blaauboer B.

Altern Lab Anim. 2008 Jul;36(3):353-66. No abstract available.

PMID:
18662098
28.

Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, Van Eerdewegh P, Bradley WE, Croteau P, Nguyen-Huu Q, Segal J, Debrus S, Allard R, Rosenstiel P, Franke A, Jacobs G, Nikolaus S, Vidal JM, Szego P, Laplante N, Clark HF, Paulussen RJ, Hooper JW, Keith TP, Belouchi A, Schreiber S.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14747-52. Epub 2007 Sep 5.

29.

[Candida folliculitis in intravenous drug users].

Recio C, Piqué E, Lluch J, Vidal JM.

Enferm Infecc Microbiol Clin. 2003 Aug-Sep;21(7):386-7. Spanish. No abstract available.

PMID:
14525698
30.

A good practice guide to the administration of substances and removal of blood, including routes and volumes.

Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal JM, van de Vorstenbosch C; European Federation of Pharmaceutical Industries Association and European Centre for the Validation of Alternative Methods.

J Appl Toxicol. 2001 Jan-Feb;21(1):15-23.

PMID:
11180276
31.

Complications after total laryngectomy in nonradiated laryngeal and hypopharyngeal carcinomas.

Herranz J, Sarandeses A, Fernández MF, Barro CV, Vidal JM, Gavilán J.

Otolaryngol Head Neck Surg. 2000 Jun;122(6):892-8.

PMID:
10828805
32.

Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapy.

Prost AC, Ménégaux F, Langlois P, Vidal JM, Koulibaly M, Jost JL, Duron JJ, Chigot JP, Vayre P, Aurengo A, Legrand JC, Rosselin G, Gespach C.

Int J Oncol. 1998 Oct;13(4):871-5.

PMID:
9735419
33.

Cloning and analysis of the coding region of the histone H1(0)-encoding gene from rat PC12 cells.

Martínez P, Vidal JM, Monsalves C, Pérez M, Pucket C, Ponte I, Suau P.

Gene. 1995 Dec 12;166(2):313-6.

PMID:
8543182
34.

Introducing anthropomorphism, discontinuities and anecdotes to question them.

Vidal JM, Vancassel M, Quris R.

Behav Processes. 1995 Dec;35(1-3):299-309.

PMID:
24896040
35.

[Medical anthropology: conceptual and methodological elements for an approach to health and disease].

Uchôa E, Vidal JM.

Cad Saude Publica. 1994 Dec;10(4):497-504. Epub 2003 Dec 15. Portuguese.

PMID:
14676936
36.

[Psychic discrepancies between animals and humans. A new light on the "autistic monad"].

Vidal JM.

Psychiatr Enfant. 1993;36(1):67-87. Review. French.

PMID:
7689734
37.

Sneddon's syndrome with antiphospholipid antibodies and arteriopathy.

Moral A, Vidal JM, Moreau I, D'Olhaberriague L, Montalbán J.

Stroke. 1991 Oct;22(10):1327-8. No abstract available.

PMID:
1926249
38.

[Primary fibroblastic tumor of the breast. Review of the literature apropos of a case of desmoid tumor of the breast posing nosologic problems with a low-grade fibrosarcoma].

Afifi A, Descamps P, Vidal JM, Devilliers JL, Bardaxoglou E.

J Gynecol Obstet Biol Reprod (Paris). 1990;19(3):309-14. Review. French.

PMID:
2161028
39.

[Seroepidemiologic evaluation of malaria in Mayotte (Comoro archipelago) 1984-1988].

Julvez J, Michault A, Galtier J, el Amine Ali Halidi M, Vidal JM.

Bull Soc Pathol Exot. 1990;83(5):658-68. French.

PMID:
2085912
40.

Laryngeal vasculitis.

Godeau B, Oberlin F, Vidal JM, Artru L, Koeger AC.

J Rheumatol. 1989 Apr;16(4):562-3. No abstract available.

PMID:
2746602
41.

[Undifferentiated epithelioma of the parotid and cystadenolymphoma. Apropos of a case].

Chomette G, Auriol M, Vidal JM, Soudant J.

Rev Stomatol Chir Maxillofac. 1989;90(4):293-6. French.

PMID:
2762748
42.

[Facial circumscribed ossifying myositis. Anatomo-clinical and tomodensitometric study].

Chomette G, Goudot P, Auriol M, Vidal JM, Tranbaloc P, Wechsler B, Vaillant JM, Guilbert F.

Rev Stomatol Chir Maxillofac. 1989;90(1):1-6. French.

PMID:
2497507
43.

[Carcinoma in situ of the cervix uteri extending to the endometrium. Apropos of 1 case].

Tranbaloc P, Foulques H, Wann AR, Vidal JM, Blondon J, Chomette G.

Arch Anat Cytol Pathol. 1988;36(3):100-3. French. No abstract available.

PMID:
3202655
44.

[Bilateral hematoma of the adrenals and thrombopenia induced by heparin].

Laurent M, Vidal JM, Tranbaloc P.

Presse Med. 1987 Apr 18;16(14):686. French. No abstract available.

PMID:
2953005
45.

[Identification of the risk of supraventricular tachyarrhythmias in the postoperative period of coronary surgery].

Durán E, Vidal JM, Kabbani Z, Pousibet H, Ajuria M, Rivera R.

Rev Esp Cardiol. 1984 Nov-Dec;37(6):440-4. Spanish. No abstract available.

PMID:
6522777
46.

Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry.

Cosio FG, Palacios J, Vidal JM, Cocina EG, Gómez-Sánchez MA, Tamargo L.

Am J Cardiol. 1983 Jan 1;51(1):122-30.

PMID:
6849250
47.

Mechanism and clinical significance of atrial repetitive responses in man.

Cosío FG, Llovet A, Vidal JM.

Pacing Clin Electrophysiol. 1983 Jan;6(1 Pt 1):53-9.

PMID:
6188125
48.

[Effect of nifedipine on myocardial perfusion. Gammagraphic evaluation using thallium 201].

Llovet A, Sáenz de la Calzada C, Díez L, Guitián R, Vidal JM, Alba F.

Rev Esp Cardiol. 1982;35(5 Suppl 2):II89-94. Spanish. No abstract available.

PMID:
7170412
49.

Preexcitation patterns in hypertrophic cardiomyopathy.

Cosio FG, Sánchez A, Vidal JM, Iglesias J, García-Martínez J.

Am Heart J. 1981 Feb;101(2):233-4. No abstract available.

PMID:
7193402
50.

Apexcardiographic index in ischemic heart disease.

Vidal JM, Saez de la Calzada C.

Am J Cardiol. 1980 Aug;46(2):348-9. No abstract available.

PMID:
7405854

Supplemental Content

Loading ...
Support Center